Company Profiles 2010
Total Page:16
File Type:pdf, Size:1020Kb
COMPANY PROFILES 2010 Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2010 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. GODSEY & GIBB COMPANY PROFILES 2010 TABLE OF CONTENTS Abbott Laboratories (ABT)……………………………………………………………………………. 1 Accenture Ltd. (ACN)…………………………………………………………………………………. 3 AFLAC Inc. (AFL)……………………………………………………………………………………… 6 AGL Resources Inc. (AGL)…………………………………………………………………………… 7 American Electric Power Co. Inc. (AEP)….………………………………………………………… 8 American Express Co. (AXP)………………………………………………………………………… 10 AT&T, Inc (T)…………………………………………………………………………………………… 13 Atmos Energy Corp. (ATO)…………………………………………………………………………… 15 Barrick Gold Corp. (ABX)……………………….……………………………………………………. 16 Chevron Corp. (CVX) ………………………………………………………………………………… 17 Clorox Co. (CLX) ……………………………………………………………………………………… 20 Cognizant Technology Solutions (CTSH)……………………………………………………….….. 21 CVS Caremark Corp. (CVS)………………………………………………………………………….. 22 Dominion Resources, Inc. (D)………………………………………………….…………………….. 23 Duke Energy Corp. (DUK)……………………………………………………………………………. 24 Emerson Electric Co. (EMR)………………………………………………………………………….. 25 Entergy Corp. (ETR)…………………………………………………………………………………… 28 Exelon Corp. (EXC)…………………………………………………………………………………… 29 Express Scripts, Inc. (ESRX)…………………………………………………………………..……. 30 ExxonMobil Corp. (XOM)………………………………………………………………….…………. 32 FedEx Corp. (FDX) …………………………………………………………………………………… 34 W.W. Grainger, Inc. (GWW)………………………………………………………………………….. 36 H. J. Heinz Co. (HNZ)…………………………………………………………………………………. 37 Hewlett-Packard Co. (HPQ)………………………………………………………………………….. 38 Intel Corp. (INTC)……………………………………………………………………………………… 41 International Business Machines Corp. (IBM)……………………………………………………… 43 Johnson & Johnson (JNJ)…………………………………………………………………………….. 44 Kimberly-Clark Corp. (KMB)…………………………………………………………………………… 45 Kraft Foods Inc. (KFT)………………………………………………………………………………….. 46 McDonald’s Corp. (MCD)……………………………………………………………………………... 48 Microchip Technologies, Inc. (MCHP)………………………………………………………………. 49 Microsoft Corp. (MSFT)……………………………………………………………………………….. 50 NextEra Energy Inc. (NEE)…………………………………………………………………………… 52 Novartis AG (NVS)……………………………………………………………………………………. 53 Nstar (NST)……………………………………………………………………………………………. 54 Oracle Corp. (ORCL)…………………………………………………………………………………. 55 Pepco Holdings, Inc. (POM)…………………………………………………………………………. 57 PepsiCo, Inc. (PEP)…………………………………………………………………………………… 59 Pfizer, Inc. (PFE) ………………..……………………………………………………………………. 61 Piedmont Natural Gas Co. (PNY)……………………………………………………………………. 63 Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2010 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. TABLE OF CONTENTS Procter & Gamble Co. (PG).………………………………………………………………………….. 64 Progress Energy, Inc. (PGN).………………………………………………………………………… 65 Qualcomm Inc. (QCOM).……………………………………………………………………………… 66 SCANA Corp. (SCG)....……………………………………………………………………………….. 68 Schlumberger Ltd. (SLB)...…………………………………………………………………………… 69 Schwab GNMA Fund (SWGSX)..……………………………………………………………………. 70 Southern Company (SO)...…………………………………………………………………………… 71 Stryker Corp. (SYK).……………..……………………………………………………………………. 72 Sysco Corp. (SYY).……………………………………………………………………………………. 75 T. Rowe Price Group, Inc. (TROW)...……………………………………………………………….. 76 Target Corp. (TGT)...………………………………………………………………………………….. 77 Teva Pharmaceutical Industries Ltd. (TEVA)..….…………..………………………………………. 78 United Technologies Corp. (UTX).………..……………..…………………………………………… 79 Vanguard GNMA Fund (VFIIX and VFIJX).…………………………………………………………. 81 Verizon Communications (VZ)...……………………………………………………………………… 82 Walgreen Company (WAG).…………………………………………………………………………… 84 Wal-Mart Stores, Inc. (WMT)....……………………………………………………………………….. 85 WGL Holdings, Inc. (WGL).……………………………………………………………………………. 86 Xcel Energy, Inc. (XEL.. ……………………………………………………………………………….. 87 Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2010 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. COMPANY PROFILE Abbott Laboratories (ABT) Web Site: http://www.abbott.com/ Abbott Laboratories (Abbott), incorporated in 1900, is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. The Company operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Pharmaceutical Products include a line of adult and pediatric pharmaceuticals manufactured, marketed, and sold directly to wholesalers, distributors, government agencies, healthcare facilities, specialty pharmacies and independent retailers from Abbott-owned distribution centers and public warehouses. Its Diagnostic Products include a line of diagnostic systems and tests manufactured, marketed, and sold to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, alternate-care testing sites and plasma protein therapeutic companies. The Company’s Nutritional Products include a line of pediatric and adult nutritional products manufactured, marketed, and sold worldwide. Its Vascular Products include a line of coronary, endovascular, and vessel closure devices for the treatment of vascular disease manufactured, marketed and sold worldwide. In March 2010, Abbott Laboratories acquired Starlims Technologies Limited. In April 2010, the Company completed its acquisition of Facet Biotech Corporation. On February 15, 2010, Abbott completed its acquisition of the Solvay Group's pharmaceuticals business. In October 2009, Abbott acquired 100% interest in Visiogen, Inc. On October 30, 2009, Abbott acquired Evalve, Inc. In February 2009, Abbott acquired Advanced Medical Optics, Inc. (AMO). In January 2009, Abbott acquired Ibis Biosciences, Inc. In September 2010, the Company acquired Piramal Healthcare Limited’s Healthcare Solutions business. Pharmaceutical Products The principal products included in the Pharmaceutical Products segment include Humira, for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis and Crohn's disease; TriCor, Trilipix, Simcor and Niaspan, for the treatment of dyslipidemia; Kaletra, Aluvia and Norvir, protease inhibitors for the treatment of human immunodeficiency virus (HIV) infection; Synthroid, for the treatment of hypothyroidism; Lupron, also marketed as Lucrin and Lupron Depot, used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia caused by uterine fibroids; Depakote, an agent for the treatment of epilepsy and bipolar disorder and the prevention of migraines; the anesthesia products sevoflurane (sold in the United States under the trademark Ultane and outside of the United States primarily under the trademark Sevorane and in a few other markets as Ultane), isoflurane and enflurane; the anti-infective clarithromycin (sold under the trademarks Biaxin, Klacid and Klaricid), and various forms of the antibiotic erythromycin, sold primarily as polymercoated erythromycin (PCE), Erythrocin and E.E.S.; Zemplar, for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease and Stage V treatment, and Ogastro (lansoprazole), a proton pump inhibitor that is marketed outside of the United States and used principally for the short-term treatment of gastroesophageal reflux disease, duodenal ulcers, gastric ulcers and erosive esophagitis. Diagnostic Products The Company’s Diagnostic Products segment's products are generally marketed and sold directly from Abbott-owned distribution centers and public warehouses and third-party distributors. Outside the United States, sales are made either directly to customers or through distributors, depending on the market served. The principal products included in the Diagnostic Products segment include immunoassay systems, which include ARCHITECT, AxSYM, IMx, Commander, Abbott PRISM, TDx and TDxFlx; chemistry systems, such as ARCHITECT c4000, c8000 and c16000; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological diseases and infectious diseases, such as hepatitis and HIV; the m2000, an instrument that automates the extraction, purification, and preparation of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from patient samples and detects and measures infectious agents including HIV, hepatitis B virus (HBV), hepatitis C virus HCV, human papillomavirus (HPV), and CT/NG; the Vysis product line of genomic-based tests, which include the PathVysion HER-2 DNA probe kit and the UroVysion bladder cancer recurrence kit; a line of hematology systems and reagents known as the Cell-Dyn series, and the i-STAT point-of-care diagnostic systems and tests for blood analysis. In addition, under a distribution agreement with